Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants

NL Galvão-Coelho, W Marx, M Gonzalez, J Sinclair… - …, 2021 - Springer
Rationale Major depressive disorder is one of the leading global causes of disability, for
which the classic serotonergic psychedelics have recently reemerged as a potential …

Novel drug developmental strategies for treatment‐resistant depression

É Borbély, M Simon, E Fuchs, O Wiborg… - British journal of …, 2022 - Wiley Online Library
Major depressive disorder is a leading cause of disability worldwide. Because conventional
therapies are ineffective in many patients, novel strategies are needed to overcome …

Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life …

S Ross, G Agin-Liebes, S Lo, RJ Zeifman… - ACS pharmacology & …, 2021 - ACS Publications
People with advanced cancer are at heightened risk of desire for hastened death (DHD),
suicidal ideation (SI), and completed suicide. Loss of Meaning (LoM), a component of …

Post-psychedelic reductions in experiential avoidance are associated with decreases in depression severity and suicidal ideation

RJ Zeifman, AC Wagner, R Watts, H Kettner… - Frontiers in …, 2020 - frontiersin.org
Psychedelic therapy shows promise as a novel intervention for a wide range of mental
health concerns but its therapeutic action is incompletely understood. In line with …

Does psychedelic therapy have a transdiagnostic action and prophylactic potential?

R Kočárová, J Horáček, R Carhart-Harris - Frontiers in Psychiatry, 2021 - frontiersin.org
Addressing global mental health is a major 21st-century challenge. Current treatments have
recognized limitations; in this context, new ones that are prophylactic and effective across …

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force report: serotonergic psychedelic treatments for major depressive disorder

JD Rosenblat, MI Husain, Y Lee… - The Canadian …, 2023 - journals.sagepub.com
Objective Serotonergic psychedelics are re-emerging as potential novel treatments for
several psychiatric disorders including major depressive disorder. The Canadian Network …

MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults

GM Jones, MK Nock - Journal of psychopharmacology, 2022 - journals.sagepub.com
Background: Suicide is one of the leading causes of death worldwide and rates within the
United States have risen over the past two decades. Hence, there is a critical need for novel …

Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open …

RJ Zeifman, N Singhal, RG Dos Santos… - …, 2021 - Springer
Rationale Suicidality is a major public health concern with limited treatment options.
Accordingly, there is a need for innovative interventions for suicidality. Preliminary evidence …

Control conditions in randomized trials of psychedelics: an ACTTION systematic review

SM Nayak, MK Bradley, BA Kleykamp… - The Journal of …, 2023 - legacy.psychiatrist.com
Results: In total, 126 articles were included, encompassing 86 unique studies. Of studies
with a drug control condition (80), 49 (61.2%) used an inert placebo control, 16 (20.0%) …

Psychedelics: alternative and potential therapeutic options for treating mood and anxiety disorders

H Lowe, N Toyang, B Steele, J Grant, A Ali, L Gordon… - Molecules, 2022 - mdpi.com
The word “psychedelic”(psyche (ie, the mind or soul) and delos (ie, to show)) has Greek
origin and was first coined by psychiatrist Humphry Osmond in 1956, who had been …